Article in Redox biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
2 authors.
Yabing ChenDepartment of Pathology, University of Alabama at Birmingham and Research Department, Birmingham Veterans Affairs Medical Center, USA; Research Department, Birmingham Veterans Affairs Medical Center, USA.
Christopher G KevilDepartments of Pathology, Molecular and Cellular Physiology, and Cellular Biology and Anatomy, LSU Health Shreveport, USA. Electronic address: ckevil@lsuhsc.edu.
Funding
Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female HeartP20GM121307 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Christopher G Kevil · 2018 to 2026
$23.6M
Molecular Signaling in Oxidative Stress-induced Vascular CalcificationR01HL092215 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YABING · 2009 to 2018
$3.6M
Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and DiseaseR01HL158097 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI CHEN, HONG, CHEN, YABING · 2021 to 2024
$3.0M
Circadian regulation of vascular agingR01HL146103 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHATHAM, JOHN C, CHEN, YABING · 2019 to 2022
$2.9M
Molecular Mechanisms Regulating Endothelial DysfunctionR01HL137229 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI CHEN, HONG, SRIVASTAVA, SANJAY · 2017 to 2020
$2.7M
Regulation of vascular smooth muscle cell function in atherosclerosisR01HL136165 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YABING · 2017 to 2020
$2.1M
CSE regulation of vascular remodelingR01HL149264 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI KEVIL, CHRISTOPHER G · 2020 to 2023
$1.7M
O-GlcNAcylation regulates vascular smooth muscle cells in diabetic vasculopathyR01DK100847 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YABING · 2014 to 2017
$1.3M
Molecular Regulation of Vascular Calcification in DiabetesI01BX004426 · VA · PORTLAND VA MEDICAL CENTER · PI CHEN, YABING · 2020 to 2024
–
BLR&D Research Career Scientist Award ApplicationIK6BX003617 · VA · BIRMINGHAM VA MEDICAL CENTER · PI CHEN, YABING · 2017 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Redox Signaling and Cardiovascular Disease: New Paradigms and discoveries. · full record | OpenQuestion